Convention Question: What Will Drive the Next Great Advance in Stroke Treatment?

Novel medications and therapies in the poststroke recovery period.

—David Hahn, MD
Stroke Neurologist
Stamford Hospital
Stamford, CT

Understanding when to start heparin and other treatments after thrombolysis/thrombectomy will be important as will preventing stroke in children and young adults, especially with potentially neuroprotective agents.

—Michael Dowling, MD, PhD
Associate Professor
Departments of Pediatrics and Neurology
UT Southwestern
Dallas, TX

Public health education about stroke.

—Shaun Schmelzen, RN
Oregon Health Sciences University
Portland, OR

Ultrarapid MRI as a replacement for CT scanning in initial triage of patients with stroke.

—Paul Johnson, MD
Intermountain Medical Center
Salt Lake, UT

Telerobotic thrombectomy.

—Michael Frankel, MD
Director, Marcus Stroke & Neuroscience Center
Grady Memorial Hospital
Professor and Director of Vascular Neurology
Emory University School of Medicine
Atlanta, GA

Primary prevention of strokes—including silent strokes—in children with sickle cell disease in high- and low-resource settings.

—Michael R. DeBaun, MD
Professor of Pediatrics and Medicine
Vanderbilt University
Nashville, TN